EUVIMEDEUVIMED entdecken
Crossref

Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma

Congyi Zhang, Shizhuan Huang, Kunhao Ding, Haotian Wu, Minghui Li, Tianwei Li, Zibo Shen, Sheng Tai, Wenhua Li iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Congyi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Carbon Monoxide, Polyethylene Glycols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Harbin Medical University, Heilongjiang Provincial Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, carbon monoxide (CO) has garnered increased attention as a novel green therapy for hepatocellular carcinoma (HCC) treatment. However, the CO donor is still limited in clinical application due to its lack of targeted ability and unstable release rate. Here, self-assembled amphiphilic nanomicelles glucose-polyethylene glycol (PEG)-lipoic acid (LA)-Fe2(CO)6 (Glu-Fe2(CO)6) are first designed as a CO donor and synthesized via a chemical method, combining glucose with Fe2(CO)6 through PEG-LA. Some advantages of this tumor-targeted Glu-Fe2(CO)6 delivery system include (I) good water-solubility, (II) the glutathione responsive CO slow release, (III) the active tumor-targeted ability of glucose as targeted ligands, and (IV) outstanding efficacy of antitumor and safety of CO therapy of HCC both in vitro and in vivo. These findings suggest that Glu-Fe2(CO)6 nanomicelles hold promise for enhancing antitumor therapeutic capabilities, presenting a novel tumor-targeted delivery strategy in gas therapy for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCarbon MonoxidePolyethylene GlycolsMicellesHumansAnimalsMiceGlucoseThioctic AcidNanoparticlesCell Line, TumorDrug Delivery SystemsMice, Inbred BALB CXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

carbon monoxidehepatocellular carcinomananodeliverytherapytumor-targeted

Substanzen

Carbon MonoxidePolyethylene GlycolsMicellesGlucoseThioctic Acid

Autor:innen und Institutionen

  • Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Department of Pharmaceutics, Harbin Medical University-Daqing Campus, 1 Xinyang Road, Daqing 163319, China.
  • Department of Biomedical and Life Science, Institute of Life Sciences & Medicine, King's College London, London SE1 1UL, U.K.

ORCID-Profile: Wenhua Li

Förderung

  • China Postdoctoral Science Foundation
  • Harbin Medical University
  • Heilongjiang Provincial Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, C., Huang, S., Ding, K., Wu, H., Li, M., Li, T., Shen, Z., Tai, S., & Li, W. (2024). Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00437

Vancouver

Zhang C, Huang S, Ding K, Wu H, Li M, Li T, et al. Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00437

BibTeX
@article{Zhang2024,
  author = {Zhang, Congyi and Huang, Shizhuan and Ding, Kunhao and Wu, Haotian and Li, Minghui and Li, Tianwei and Shen, Zibo and Tai, Sheng and Li, Wenhua},
  title = {Tumor-Targeted CO Nanodelivery System Design and Therapy for Hepatocellular Carcinoma},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00437}
}
Kostenlos starten →